SAMUEL LYNCH: Open Payments
NPI 1649972431 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 9 payments from 4 companies in 2025. Trend: 2023 $728 · 2024 $1,147 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $144 |
| ABBVIE INC. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
Products named: CAPLYTA, UBRELVY, Cologuard Collection Kit, BREZTRI, AIRSUPRA, QULIPTA.
Industry payments across IA — which companies pay providers there.
